Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Peer Review reports

Original Submission
16 Mar 2006	Submitted	Original manuscript
7 Apr 2006	Reviewed	Reviewer Report - Henry Friedman
16 Apr 2006	Reviewed	Reviewer Report - Jerome Posner
28 Sep 2006	Author responded	Author comments - Dirk Vordermark
Resubmission - Version 2
28 Sep 2006	Submitted	Manuscript version 2
28 Sep 2006	Author responded	Author comments - Dirk Vordermark
Resubmission - Version 3
28 Sep 2006	Submitted	Manuscript version 3
16 Oct 2006	Author responded	Author comments - Dirk Vordermark
Resubmission - Version 4
16 Oct 2006	Submitted	Manuscript version 4
18 Oct 2006	Author responded	Author comments - Dirk Vordermark
Resubmission - Version 5
18 Oct 2006	Submitted	Manuscript version 5
Publishing
18 Oct 2006	Editorially accepted
18 Oct 2006	Article published	10.1186/1471-2407-6-247

Back to article page